MedTrace Logo

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia

NCT01373957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2014-07-11

No results posted yet for this study

Summary

EPICOR-RUS is a multi-centre, observational, prospective, longitudinal cohort study which will include patients, in a real-life setting, who are hospitalized for acute coronary syndrome (ACS) within 24 hours of symptom onset and who have a final diagnosis of Unstable Angina (UA), ST-Elevation Myocardial Infarction (STEMI) or Non-ST-Elevation Myocardial Infarction (NSTEMI). Patients will undergo clinical assessments and receive the standard medical care as determined by the treating cardiologist. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the EPICOR-RUS observational study.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Alexey Stepanov · AstraZeneca

  • Mikhail Ruda · RKNPK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01373957 on ClinicalTrials.gov